Symposia
Child / Adolescent - Anxiety
Jonathan Comer, Ph.D. (he/him/his)
Florida International University
Miami, FL, United States
Jonathan Comer, Ph.D. (he/him/his)
Florida International University
Miami, FL, United States
Donna Pincus, PhD
Professor
Boston University
Boston, MA, United States
Molly Adrian, Ph.D. (she/her/hers)
Associate Professor
University of Washington
Seattle, WA, United States
Jami M. Furr, Ph.D.
Clinical Associate Professor, Senior Psychologist
Florida International University
Weston, FL, United States
Dana McMakin, Ph.D.
Associate Professor
Florida International University, Department of Psychology
Miami, FL, United States
Rheanna Platt, M.P.H., M.D.
Assistant Professor of Psychiatry and Behavioral Sciences
Johns Hopkins University School of Medicine
Baltimore, MD, United States
Ronald Rapee, Ph.D. (he/him/his)
Distinguished Professor
Maquarie University
Sydney, New South Wales, Australia
Andrea Spencer, MD, MPH (she/her/hers)
Vice Chair
Ann & Robert Lurie Children's Hopsital of Chicago/Northwestern University Feinberg School of Medicine
Chicago, IL, United States
Michelle Porche, Ed.D. (she/her/hers)
Professor
UC Riverside School of Medicine
Riverside, CA, United States
Lisa Fortuna, MD, MPH (she/her/hers)
Professor and Chair
UC Riverside School of Medicine
Riverside, CA, United States
CBT is a “gold standard” psychological treatment for pediatric anxiety, but care barriers limit CBT accessibility, with minoritized youth particularly underserved. Modern CBT formats draw on varying levels of therapist involvement and differential technologies to overcome barriers, but much is unknown about their comparative effectiveness in typical care settings. The Kids Formats of Anxiety Care Effectiveness study For Extending the Acceptability and Reach of Services (Kids FACE FEARS) trial (N=305) is a recently completed multisite, pragmatic randomized trial comparing Therapist-Led CBT (telehealth, office-based, or hybrid) versus Guided Online CBT (with minimal therapist support) for treating youth anxiety. Treatment was offered in English and Spanish to youth ages 7-18 years. Families were enrolled in 4 US regions from high-volume, urban health sites affiliated with major medical centers. Families were randomized and provided treatment for up to 20 weeks. Treatment was integrated into the natural flow of usual care and implemented by routine care providers (i.e., non-research therapists). Major assessments were conducted at baseline, midtreatment, post, and 1-year follow-up. Sample demographics make Kids FACE FEARS one of the larger, more diverse, and more representative trials of CBT for pediatric anxiety (61% female; M age=11.9 years; >70% youth of color, 39% with foreign-born caregivers; 23% experiencing resource insecurity). We will describe this landmark study’s rationale, stakeholder partnerships, sample, design and methodology, and—for the first time at a conference—we will present the main outcomes (currently under embargo). These include comparative effectiveness findings on anxiety severity, responder rates, perceived treatment effectiveness, and treatment satisfaction. Findings will be discussed in terms of their ability to improve treatment efficiency, inform patient-centered decision-making, and help tailor treatment selections for anxious youth.